1244030-73-6Relevant articles and documents
4-aryl-4h-chromene-3-carbonitrile derivatives: Evaluation of Src kinase inhibitory and anticancer activities
Fallah-Tafti, Asal,Tiwari, Rakesh,Shirazi, Amir Nasrolahi,Akbarzadeh, Tahmineh,Mandal, Deendayal,Shafiee, Abbas,Parang, Keykavous,Foroumadi, Alireza
experimental part, p. 466 - 472 (2012/06/05)
Src kinase mutations and/or overexpression have been implicated in the development of a number of human cancers including colon, breast, and lung cancers. Thus, designing potent and selective Src kinase inhibitors as anticancer agents is a subject of majo